Immunocore appoints Bahija Jallal as Chief Executive Officer

(Oxford, UK and Conshohocken, US, 4 January 2019) Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announces that Bahija Jallal has been appointed as Chief Executive Officer and Director of the Board. 

 

Read the full press releaseCompany website